Atlas Trials

Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment

Clinical trial NCT02348502 · UNKNOWN

Trial details

NCT number
NCT02348502
Sponsor
Beijing Ditan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis B
Start date
2013-01-01
Primary completion
2016-12-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.